Europe Non-alcoholic Steatohepatitis Biomarkers Market Size & Outlook

The non-alcoholic steatohepatitis biomarkers market in Europe is expected to reach a projected revenue of US$ 1,319.1 million by 2030. A compound annual growth rate of 22.5% is expected of Europe non-alcoholic steatohepatitis biomarkers market from 2022 to 2030.
Revenue, 2021 (US$M)
$212.3
Forecast, 2030 (US$M)
$1,319.1
CAGR, 2022 - 2030
22.5%
Report Coverage
Europe

Europe non-alcoholic steatohepatitis biomarkers market, 2018-2030 (US$M)

Europe

Related Markets

Europe non-alcoholic steatohepatitis biomarkers market highlights

  • The Europe non-alcoholic steatohepatitis biomarkers market generated a revenue of USD 212.3 million in 2021.
  • The market is expected to grow at a CAGR of 22.5% from 2022 to 2030.
  • In terms of segment, serum biomarkers was the largest revenue generating type in 2021.
  • Hepatic Fibrosis Biomarkers is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, France is expected to register the highest CAGR from 2022 to 2030.


Europe data book summary

Market revenue in 2021USD 212.3 million
Market revenue in 2030USD 1,319.1 million
Growth rate22.5% (CAGR from 2021 to 2030)
Largest segmentSerum biomarkers
Fastest growing segmentHepatic Fibrosis Biomarkers
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationSerum Biomarkers, Hepatic Fibrosis Biomarkers, Apoptosis Biomarkers, Oxidative Stress Biomarkers
Key market players worldwideGenfit SA, Siemens AG, Quest Diagnostics Inc, AstraZeneca PLC, Meridian Bioscience, Labcorp Holdings Inc, Pfizer Inc, Bristol-Myers Squibb Co


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.9% of the global non-alcoholic steatohepatitis biomarkers market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 925.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Non-alcoholic Steatohepatitis Biomarkers Market Companies

Name Profile # Employees HQ Website

Europe non-alcoholic steatohepatitis biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-alcoholic steatohepatitis biomarkers market will help companies and investors design strategic landscapes.


Serum biomarkers was the largest segment with a revenue share of 32.83% in 2021. Horizon Databook has segmented the Europe non-alcoholic steatohepatitis biomarkers market based on serum biomarkers, hepatic fibrosis biomarkers, apoptosis biomarkers, oxidative stress biomarkers covering the revenue growth of each sub-segment from 2018 to 2030.


Europe was estimated to be the second-largest market due to the presence of prominent research institutes and market players operating in this region. Market growth can be attributed to increasing collaborations between European universities and biomarker solution providers.

Moreover, the European Alliance of Medical Research Infrastructures (AMRI) makes strategies and helps improve the research process related to diagnostics tests & biomarker development. Several initiatives undertaken by government and private organizations to fund R&D pertaining to biomarkers and create awareness about the benefits of biomarkers are expected to boost the market.

Major factors responsible for NASH are diabetes and obesity. This depicts the high untapped opportunity for companies to improve sales in the European region by increasing awareness related to prognostic usage of biomarkers by patients with underlying conditions.

Reasons to subscribe to Europe non-alcoholic steatohepatitis biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe non-alcoholic steatohepatitis biomarkers market databook

  • Our clientele includes a mix of non-alcoholic steatohepatitis biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe non-alcoholic steatohepatitis biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into Europe non-alcoholic steatohepatitis biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe non-alcoholic steatohepatitis biomarkers market size, by country, 2018-2030 (US$M)

Europe Non-alcoholic Steatohepatitis Biomarkers Market Outlook Share, 2021 & 2030 (US$M)

Europe non-alcoholic steatohepatitis biomarkers market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more